Illumina (LTS:0J8Z) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0J8Z Illumina Inc LTS:0J8Z
73 GF Score
Price $193.53
GF Value $131.12
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Illumina Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

LTS:0J8Z
73GF Score
Illumina Inc LTS:0J8Z
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Illumina (LTS:0J8Z) Overvalued in 2026?

Based on GuruFocus' analysis, Illumina stock appears to be overvalued. The current stock price of $193.53 is trading 47.6% above its estimated GF Value™ of $131.12. GuruFocus considers Illumina to be Significantly Overvalued.

Key valuation signals for LTS:0J8Z:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $131.12 vs. price of $193.53 (47.6% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the LTS:0J8Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Illumina Business Description

Address 5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
73GF Score

Get the complete analysis for LTS:0J8Z

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$193.53
Price
$131.12
GF Value